Children younger than 10 will probably need two doses of the pandemic H1N1 vaccine for optimal protection, according to an interim analysis of a randomized, controlled trial.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Senate Finance Committee voted 14 to 9 to send its healthcare reform bill to the full Senate, with one Republican on the panel voting to support the $829 billion package.
No Comments »
Filed under: General Health News
When comparing hospitals on their quality of care for heart failure, it is important to include data on all patients, not just those who died, researchers found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA issued a strict warning to four drug manufacturers today: stop making unapproved and illegal codeine sulfate tablets.
No Comments »
Filed under: Pharmacy News
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company’s proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug [...]
No Comments »
Filed under: Pharmacy News
ZIOPHARM Oncology, Inc. announced today positive top line interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. The analysis evaluated 62 patients treated as of the end of September, with 58 being analyzed.
No Comments »
Filed under: Pharmacy News
ArQule, Inc. today announced that the European Medicines Evaluation Agency (EMEA) has designated ARQ 197 as an orphan medical product for the treatment of soft tissue sarcoma.
No Comments »
Filed under: Pharmacy News
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has expanded its compassionate use program for PV-10, making the agent, which is being developed as a therapeutic agent for a broad spectrum of cancers, available for select cancer patients in the United States. The program is already in progress in Australia, where it was [...]
No Comments »
Filed under: Pharmacy News
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced the initiation of a Phase I/IIa dose escalation study of patients suffering from idiopathic CD4 lymphocytopenia (ICL).
No Comments »
Filed under: Pharmacy News
Nobilon, the human vaccine business unit of Schering-Plough Corporation (NYSE: SGP), today announced that it has initiated a clinical Proof of Concept trial with SCH 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) for annual seasonal use.
No Comments »
Filed under: Pharmacy News
